Chemo Pharma Laboratories Ltd

₹ 82.1 1.41%

22 Nov - close price

thechemopharmalaboratoriesltd.com BSE: 506365

About

The Chemo Pharma Laboratories Limited was established in 1942 and was making Pharmaceuticals and bulk drugs. However due to increased competition, Company disposed the business. Company is in advanced stage of negotiation to diversify and take over a sick company^[1]

Key Points

Background^[1]
The Chemo Pharma Laboratories Limited was established in 1942 and has been making pharmaceuticals and diversified into bulk drugs. However due to increase in competition and flow of new drugs, Company disposes their business and pay all its liabilities and dues. Presently the Company has its own cash resource, with this the Company is proposing to diversify and to take over Sick Company which has excellent future potential. The Company is in advance in the negotiation to some other company and soon rehab to acquire business in Power and Chemicals.

Website BSE

Market Cap ₹ 12.3 Cr.
Current Price ₹ 82.1
High / Low ₹ 94.7 / 40.4
Stock P/E 9.86
Book Value ₹ 91.1
Dividend Yield 0.00 %
ROCE 13.3 %
ROE 9.67 %
Face Value ₹ 10.0

Add ratio to table

Edit ratios

Pros

Company is almost debt free.
Stock is trading at 0.90 times its book value

Cons

Though the company is reporting repeated profits, it is not paying out dividend
Promoter holding is low: 27.9%
Company has a low return on equity of 4.59% over last 3 years.
Earnings include an other income of Rs.1.88 Cr.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs

Edit Columns

Loading peers table ...

Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	0.07	0.08	0.18	0.12	0.05	0.02	0.02	0.05	0.02	0.02	0.10	0.05	0.02
Operating Profit	-0.07	-0.08	-0.18	-0.12	-0.05	-0.02	-0.02	-0.05	-0.02	-0.02	-0.10	-0.05	-0.02
OPM %
	0.19	0.36	0.13	-0.38	0.59	0.19	-0.10	0.43	0.46	0.70	0.25	0.30	0.63
Interest	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation	0.01	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Profit before tax	0.11	0.27	-0.05	-0.50	0.54	0.17	-0.12	0.38	0.44	0.68	0.15	0.25	0.61
Tax %	0.00%	0.00%	-400.00%	0.00%	0.00%	0.00%	25.00%	0.00%	0.00%	0.00%	293.33%	0.00%	0.00%
	0.11	0.28	0.14	-0.50	0.53	0.16	-0.15	0.38	0.44	0.68	-0.29	0.25	0.61
EPS in Rs	0.73	1.87	0.93	-3.33	3.53	1.07	-1.00	2.53	2.93	4.53	-1.93	1.67	4.07
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	0.09	0.13	0.12	0.17	0.27	0.34	0.56	0.48	0.34	0.41	0.20	0.19	0.19
Operating Profit	-0.09	-0.13	-0.12	-0.17	-0.27	-0.34	-0.56	-0.48	-0.34	-0.41	-0.20	-0.19	-0.19
OPM %
	0.27	0.44	0.50	0.49	5.61	1.11	0.82	1.00	0.67	0.79	0.30	1.84	1.88
Interest	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.01	0.00	0.00
Depreciation	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.02	0.02	0.02	0.01	0.01	0.00
Profit before tax	0.17	0.31	0.38	0.32	5.34	0.77	0.26	0.50	0.31	0.36	0.08	1.64	1.69
Tax %	23.53%	19.35%	26.32%	31.25%	12.17%	85.71%	19.23%	16.00%	19.35%	-55.56%	37.50%	26.83%
	0.14	0.24	0.28	0.22	4.68	0.10	0.21	0.42	0.25	0.56	0.05	1.20	1.25
EPS in Rs	0.93	1.60	1.87	1.47	31.20	0.67	1.40	2.80	1.67	3.73	0.33	8.00	8.34
Dividend Payout %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Compounded Sales Growth
10 Years:	%
5 Years:	%
3 Years:	%
TTM:	%

Compounded Profit Growth
10 Years:	17%
5 Years:	41%
3 Years:	68%
TTM:	51%

Stock Price CAGR
10 Years:	9%
5 Years:	67%
3 Years:	42%
1 Year:	91%

Return on Equity
10 Years:	4%
5 Years:	4%
3 Years:	5%
Last Year:	10%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Sep 2024
Equity Capital	1.50	1.50	1.50	1.50	1.50	1.50	1.50	1.50	1.50	1.50	1.50	1.50	1.50
Reserves	3.11	3.35	3.62	3.84	8.52	8.62	8.83	9.24	9.49	10.05	10.10	11.30	12.16
	0.00	0.00	0.00	0.00	0.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	0.27	0.35	0.46	0.20	0.58	0.13	0.09	0.22	0.06	0.11	0.02	0.21	0.04
Total Liabilities	4.88	5.20	5.58	5.54	10.72	10.25	10.42	10.96	11.05	11.66	11.62	13.01	13.70
	0.02	0.01	0.00	0.00	0.01	0.00	0.00	0.07	0.05	0.04	0.03	0.02	0.02
CWIP	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Investments	1.68	1.68	1.68	1.68	0.02	0.02	0.04	0.02	0.04	2.94	3.03	4.40	4.39
	3.18	3.51	3.90	3.86	10.69	10.23	10.38	10.87	10.96	8.68	8.56	8.59	9.29
Total Assets	4.88	5.20	5.58	5.54	10.72	10.25	10.42	10.96	11.05	11.66	11.62	13.01	13.70

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
	-0.39	-0.16	-0.05	-0.43	6.41	-1.66	-5.48	4.83	-0.41	-0.33	-0.68	0.72
	0.22	0.13	0.25	0.49	0.52	1.08	0.79	1.01	-0.19	0.97	0.63	-0.52
	0.00	0.00	0.00	0.00	-0.50	1.37	0.00	0.00	1.96	-2.12	-0.08	-0.15
Net Cash Flow	-0.17	-0.03	0.20	0.06	6.43	0.79	-4.70	5.84	1.36	-1.49	-0.13	0.05

Ratios

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days
Inventory Days
Days Payable
Cash Conversion Cycle
Working Capital Days
ROCE %	3.70%	6.55%	7.62%	6.12%	3.62%	7.60%	2.54%	4.75%	2.85%	1.33%	0.78%	13.28%

Shareholding Pattern

Numbers in percentages

14 Recently

	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
	27.89%	27.89%	27.89%	27.88%	27.88%	27.88%	27.88%	27.88%	27.88%	27.88%	27.88%	27.88%
	0.17%	0.17%	0.17%	0.17%	0.17%	0.17%	0.17%	0.17%	0.17%	0.17%	0.17%	0.17%
	71.95%	71.95%	71.95%	71.94%	71.95%	71.95%	71.95%	71.95%	71.95%	71.94%	71.95%	71.95%
No. of Shareholders	6,213	6,225	6,226	6,226	6,274	6,289	6,268	6,275	6,254	6,262	6,254	6,382

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Sep 2024
	27.89%	27.89%	27.89%	27.89%	27.89%	27.89%	27.88%	27.88%	27.88%
	0.53%	0.53%	0.53%	0.53%	0.28%	0.17%	0.17%	0.17%	0.17%
	71.59%	71.59%	71.59%	71.59%	71.83%	71.95%	71.95%	71.94%	71.95%
No. of Shareholders	6,006	5,984	5,956	5,922	5,949	6,225	6,289	6,262	6,382

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

All

Chemo Pharma Laboratories Ltd

Chemo Pharma Laboratories Ltd

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flows

Ratios

Shareholding Pattern

Documents

Announcements

Annual reports